Selective Serotonin Reuptake Inhibitors for Stroke Recovery

Affiliations

• ¹ NHS Greater Glasgow and Clyde Health, Paisley, United Kingdom (L.A.L.).
• ² Department of Medicine, Mater Dei Hospital, Msida, Malta (R.T.).
• ³ Division of Geriatrics and Gerontology, Departments of Internal Medicine and Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan (C.-F.H.).
• ⁴ Department of Neurology, West China Hospital, Sichuan University, Chengdu, China (S.W.).
• ⁵ Department of Neuroscience, Neurology, Uppsala University, Sweden (E.L.).
• ⁶ Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden (A.-S.R.).
• ⁷ Department of Neurology, Danderyd Hospital, Sweden (A.-S.R.).
• ⁸ Department of Neurology, Neurosurgery and Medical Genetics, Bashkir State Medical University, Ufa, Russian Federation (M.A.K.).
• ⁹ Centre for Clinical Brain Sciences (M.D.), University of Edinburgh, United Kingdom.
• ¹⁰ Department of Stroke Medicine, Royal Infirmary of Edinburgh, United Kingdom (B.S.).
• ¹¹ Department of General Medicine, Borders General Hospital, Melrose, United Kingdom (B.S.).
• ¹² Department of Geriatric Medicine (A.B), University of Edinburgh, United Kingdom.
• ¹³ The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia (M.L.H.).
• ¹⁴ Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Australia (G.J.H.).
• ¹⁵ Centre for Clinical Brain Sciences (G.E.M.), University of Edinburgh, United Kingdom.